ClassID:

92494

C07C211/53 - CPC Classification

Classification description:

Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring having the nitrogen atom of at least one of the amino groups further bound to a hydrocarbon radical substituted by amino groups

Recent Application in this class:
#1
20240425517
2024-12-26

NOVEL COMPOUND FOR DEGRADATION OF TARGET PROTEIN OR POLYPEPTIDE BY POLYUBIQUITINATION

#2
20240279158
2024-08-22

NOVEL COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT EMITTING DEVICE INCLUDING SAME

#3
20230406812
2023-12-21

NOVEL AMINOAROMATIC COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES COMPRISING SAME AS ACTIVE INGREDIENT

#4
20230117592
2023-04-20

LIPOXYGENASE INHIBITORS

#5
20220315523
2022-10-06

Vesicular Monoamine Transporter-2 Ligands and Their Use in the Treatment of Psychostimulant Abuse

#6
20220096999
2022-03-31

MATERIALS INCLUDING ALKYL DIAMINE-SUBSTITUTED ARYL COMPOUNDS, METHODS OF MAKING, AND METHODS OF SEPARATING CO2

#7
20220040174
2022-02-10

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

#8
20210401836
2021-12-30

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

#9
20210315895
2021-10-14

Benzathine analogs

#10
20200316040
2020-10-08

Bis-amines, compositions, and uses related to CXCR4 inhibition

#11
20200290948
2020-09-17

Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse

#12
20200113900
2020-04-16

Benzathine analogs

#13
20190381042
2019-12-19

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

#14
20190374541
2019-12-12

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

#15
20190330447
2019-10-31

Polymerization initiator composition, preparation method therefor, and method for preparing polymer using same

#16
20190308931
2019-10-10

Compound and intermediate thereof

#17
20190091222
2019-03-28

Benzathine analogs

#18
20190008840
2019-01-10

Bis-amines, compositions, and uses related to CXCR4 inhibition

#19
20180104243
2018-04-19

Tricyclic Amino Containing Compounds for Treatment or Prevention of Symptoms Associated with Endocrine Dysfunction

#20
20170204036
2017-07-20

Chiral diamine compounds for the preparation of chiral alcohols and chiral amines

#21
20170166727
2017-06-15

Rubber composition, tire, amine compound, and anti-aging agent

#22
20170155047
2017-06-01

Electronic device and compound

#23
20170137604
2017-05-18

Rubber composition, tire, bisphenyldiamine compound, and anti-aging agent

#24
20160237040
2016-08-18

Benzathine analogs

#25
20160235747
2016-08-18

FBXO3 inhibitors

#26
20160046587
2016-02-18

Preparation and method for use in the treatment of respiratory diseases

#27
20150307680
2015-10-29

Organo-amine acid gas adsorption-desorption polymers, processes for preparing same, and uses thereof

#28
20150307661
2015-10-29

Organo-amine acid gas adsorption-desorption polymers, processes for preparing same, and uses thereof

#29
20150306535
2015-10-29

Organo-amine acid gas adsorption-desorption polymers, processes for preparing same, and uses thereof

#30
20150152041
2015-06-04

Benzathine analogs

#31
20140248236
2014-09-04

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

#32
20140245541
2014-09-04

Oxidation dye precursors

#33
20140011857
2014-01-09

Small molecules as epigenetic modulators of lysine-specific demethylase 1 and methods of treating disorders

#34
20130289076
2013-10-31

Cyclopropylamine inhibitors of oxidases

#35
20120164043
2012-06-28

Organo-amine acid gas adsorption-desorption polymers, processes for preparing same, and uses thereof

#36
20120004310
2012-01-05

NON-PEPTIDE BDNF NEUROTROPHIN MIMETICS

#37
20110207599
2011-08-25

Processes for the preparation of arylamine compounds

#38
20110105736
2011-05-05

SEPARATING AGENT FOR PROTEIN PURIFICATION AND PROTEIN PURIFICATION METHOD

#39
20110077421
2011-03-31

Highly Z-selective olefins metathesis

#40
20110065960
2011-03-17

Method for producing diphenylmethane diamine

#41
20090292129
2009-11-26

Process for resolving racemic mixtures and a diastereoisomeric complex of a resolving agent and an enantiomer of interest

#42
20080317806
2008-12-25

Antiparasitic Compounds

#43
20080300298
2008-12-04

Honokiol Derivates For the Treatment of Proliferative Disorders

#44
20080234281
2008-09-25

Mitotic kinesin inhibitors

#45
20080033052
2008-02-07

Dermal anesthetic compounds and pharmaceutical compositions for inducing local anesthesia and mitigating neuropathic pain

#46
20070224370
2007-09-27

Liquid-crystal aligning agent, liquid-crystal alignment film comprising the same, and liquid-crystal element

#47
20070169287
2007-07-26

P-diaminobenzene derivatives and dyes containing these compounds

#48
20070073030
2007-03-29

Chain extenders

#49
20070011829
2007-01-18

Novel double para-phenylenediamines joined by a linkage comprising an atom chosen from sulphur and nitrogen and method for dyeing keratinous fibers

#50
20070011828
2007-01-18

Novel double para-phenylenediamines joined by a branched aliphatic group and method of dyeing keratin fibers

#51
20060148893
2006-07-06

Chemical compounds

#52
20060053569
2006-03-16

Double secondary para-phenylenediamine compounds, dye compositions comprising same, and dyeing process using the compositions

#53
20050192324
2005-09-01

Dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereof

#54
20050132507
2005-06-23

Tertiary p-phenylenediamines, dyes compositions, and dyeing processes

#55
20050113574
2005-05-26

Methods and compositions comprising diamines as new anti-tubercular therapeutics

#56
17365924
2025-07-01

Organic color center-tailored, semiconducting carbon nanotubes and their method of manufacture